BRIEF REPORT ELEVATED T-CELL RESPONSE IN LIVER OF MICE VACCINATED WITH ATTENUATED KOREA VACCINIA VIRAL VACCINE EXPRESSING PLASMODIUM VIVAX CIRCUMSPOROZOITE PROTEIN

Tae Yun Kim1*, Eun-Jeong Yang2*, Hyun-Il Shin1, Sang-Won Lee3, Shin-Hyeong Cho1, Sang-Eun Lee1 and Jung-Yeon Kim1

Authors

  • ojsadmin ojsadmin

Keywords:

Plasmodium vivax, circumsporozoite protein, malaria, vaccine, vaccinia virus

Abstract

Relapse and recurrence of vivax malaria is still a major issue in temperate regions including Korea. Recombinant attenuated vaccinia virus KVAC103 expressing circumsporozoite protein (CSP), one of the main antigenic proteins of Plasmodium vivax, (KVAC-PvCSP) was generated and evaluated for its potential as an anti-malarial vaccine. Mice were subcutaneously inoculated twice with KVAC-PvCSP, with a three-week interval between injections, and cellular as well as humoral immune responses, including memory B cell response, were examined. Serial inoculation of KVAC-PvCSP elicited strong IgG production in mice. Moreover, CD3+, CD4+ and CD8+ T-cells were increased by vaccination in mouse hepatocytes, but not in splenocytes. Thus, serial KVAC-PvCSP vaccination elicited CD4+ and CD8+ T-cell responses in the liver of mice. These results suggest KVAC103-based vaccination may be useful for targeting pre-erythrocytic stages of vivax malaria.

Published

2020-06-11